Mersana Therapeutics, Inc. (MRSN)
28.23
+0.12
(+0.43%)
USD |
NASDAQ |
Dec 11, 16:00
28.24
+0.01
(+0.04%)
After-Hours: 20:00
Mersana Therapeutics Free Cash Flow: -74.37M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Day One Biopharmaceuticals, Inc. | -124.86M |
| Cidara Therapeutics, Inc. | -132.94M |
| Cue Biopharma, Inc. | -29.82M |
| Scholar Rock Holding Corp. | -274.64M |
| ETHZilla Corp. | -19.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.192M |
| Cash from Investing (Quarterly) | 0.372M |
| Cash from Financing (Quarterly) | -17.76M |
| Free Cash Flow Per Share (Quarterly) | -0.6393 |
| Free Cash Flow to Equity (Quarterly) | 15.14M |
| Free Cash Flow to Firm (Quarterly) | -3.176M |
| Free Cash Flow Yield | -4.08% |